Eurofins Scientific Societe Europeenne

Eurofins Publishes Method for Early Detection of Asymptomatic SARS-CoV-2 Virus Spreaders, That Does Not Require Human PCR Clinical Testing

Regulatory News:

Eurofins (Paris:ERF):

Although employees showing COVID-19 symptoms are currently discouraged from going to work, significant workplace COVID-19 outbreaks continue to occur. Virus spread by asymptomatic SARS-CoV-2 infected individuals has been reported to be a significant cause of contamination clusters. Yet, other than PCR testing every employee each day using an invasive nasal or nasopharyngeal swab, few options exist to detect asymptomatic virus spreaders who can contaminate other employees or visitors.

Following an extensive study (1) involving over 6,300 PCR tests at nine office and industrial locations in Europe and North America, Eurofins demonstrated that its Eurofins COVID-19 SentinelTM RT-PCR environmental surfaces tests can contribute to detecting asymptomatic virus spreaders.

Eurofins is launching Eurofins COVID-19 SentinelTM worldwide today as part of its SAFER@WORK™ programme. Through a comprehensive range of testing solutions, including waste water testing, work environment surface testing and worn mask testing, Eurofins COVID-19 Sentinel™ provides an early warning of the presence of SARS-CoV-2 at a given site (e.g. a city, factories, education, government and public service sites, nursing homes), before the virus spreads too broadly. If positive results are found employees present in the rooms tested can be isolated and advised to get tested by clinical RT-PCR.

In response to the COVID-19 pandemic, governments and employers have deployed a set of measures to control the spread of the SARS-CoV-2 virus in workplaces including regular employee testing. Due to barriers to personal testing, such as inconvenience, expense and invasiveness, businesses, education, public and government bodies are looking for non-invasive cost-effective ways for early outbreak detection.

This is why Eurofins developed the Eurofins COVID-19 SentinelTM programme, which is affordable, easily organised and non-invasive. It allows governments and companies to early detect the presence of asymptomatic and pre-symptomatic virus carriers, at times before anyone is aware of the issue, and to assess effectiveness of workplace COVID-19 management plans.

(1) Sentinel Coronavirus Environmental Monitoring Can Contribute to Detecting Asymptomatic SARS-CoV-2 Virus Spreaders and Can Verify Effectiveness of Workplace COVID-19 Controls

The full release can be found at:

For further information, please visit

About Eurofins, the global leader in Bioanalysis

With over 47,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

EN
01/07/2020

Reports on Eurofins Scientific Societe Europeenne

Eurofins Scientific S.E: 1 director

A director at Eurofins Scientific S.E sold 400 shares at 54.720EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

Bruno de La Rochebrochard
  • Bruno de La Rochebrochard

EUROFINS SCIENTIFIC: FY guidance again upgraded after strongest H1 res...

EUROFINS SCIENTIFIC - BUY | EUR125 FY guidance again upgraded after strongest H1 results Results again supported by Covid activities FY guidance again revised upwards

Bruno de La Rochebrochard
  • Bruno de La Rochebrochard

EUROFINS SCIENTIFIC: Q1 IMS: Trends that remain largely positive | BUY...

EUROFINS SCIENTIFIC - BUY | EUR125 Q1 IMS: Trends that remain largely positive Good start, ahead expectation Guidance which sounds to us still conservative

Bruno de La Rochebrochard
  • Bruno de La Rochebrochard

EUROFINS SCIENTIFIC - BUY | EUR125 FY results: Far beyond management e...

Largely exceed expectations Guidance revisited but sound to us conservative

Bruno de La Rochebrochard
  • Bruno de La Rochebrochard

EUROFINS SCIENTIFIC - BUY vs. NEUTRAL | EUR125

EUROFINS SCIENTIFIC - BUY vs. NEUTRAL | EUR125(+33%) Back to Buy recommendation after recent share price consolidation (contact) Good surprises to be expected in the short term… …and the medium term Strong financials allowing the group to remain on the look-out for all opportunities Buy vs Neutral after recent share price consolidation. TP of EUR125 confirmed

ResearchPool Subscriptions

Get the most out of your insights

Get in touch